Listed below are the Principal Investigators for our current call. Have a look through their research programme description and key words, and explore the links to their more detailed UCD profiles.
Once you have identified a potential supervisor, get in touch with them! This is a critical step as it gives you the chance to find out more about their lab and to see if you would be happy working with them. Once you have decided on your supervisor, you will work with them to formulate the project proposal that you will submit to the programme.
Dolores’ area of research is in proteomics, protein arrays and biomarker validation. She has successfully commercialised her research in Protagen AG involved in commercialisation of companion diagnostics and Protagen Contract Services. She is now exploring application in personalised medicine and diagnostic contract services.
anti-TNF | inflammatory bowel disease | faecal calprotectin | therapeutic drug monitoring | monoclonal antibody
Glen’s interests include translational research to personalise therapy for inflammatory bowel diseases (Crohn’s Disease and Ulcerative Colitis) by optimising anti-TNF dosing and discovery of biomarkers/mechanisms of primary and secondary non- response.
cancer biology | transcriptomics | molecular diagnostics | therapeutics | breast
William’s team looks to deliver optimal management of cancer diagnosis and treatment via efficient use of protein and/or RNA-based biomarkers, digital pathology and systems medicine tools.
blindness | drug discovery | proteomics | neuroprotectants
Breandán’s research utilises phenotype-based assays to discover and develop novel drugs and new therapeutic targets for blindness and cancer. In parallel, CRISPR technology functionally interrogates gene networks and generates disease models.
Patricia and Fionnuala co-direct SPHERE, a UCD Conway Institute-based research group. They aim to harness unique haematological tools to diagnose and understand a host of inflammatory-based diseases.
nutrigenomics | precision nutrition | molecular nutrition | personalised nutrition & health
Helen’s team uses high throughput data approaches to further understand the interactions between nutritional status and metabolic health; we are actively looking to develop advanced systems biology models and approaches to support this work.
cancer | genetics | proteomics | bioinformatics | systems biology
Colm's research uses network biology approaches to identify vulnerabilities associated with specific genetic aberrations in cancer.
skin research | inflammation | oncology | omics technology | immunity
Martin’s translational research addresses how the immune and nervous system communicate and influence skin diseases using -omics, imaging, molecular biology, immunology, in-vivo models, human studies.
inflammation | tissue damage | genetics | epigenetics | patient stratification
Gerry’s research area is identification of prognostic and therapeutic response biomarkers in rheumatoid arthritis and functional studies on pathways regulating inflammation-related tissue damage.